Buy Insecticides India; target of Rs 949: Sharekhan

Buy

Sharekhan's research report on Insecticides India

Revenues stood at Rs. 627 crore, down 10% y-o-y and 5% q-o-q, 12% below our estimates. EBITDA came in at Rs. 90 crore, marking a 29% y-o-y increase but a 1% decline q-o-q, beating estimates by 7%. Margins were at 14%, rising by 251 bps y-o-y and 339 bps q-o-q. PAT stood Rs. 61 crore, up 47% y-o-y and 19% q-o-q, surpassing estimates by 8%.

Outlook

We retain a Buy rating with a revised PT of Rs. 949. Valuation of 19x/16x its FY2025E/FY2026E EPS is deemed justified.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Insecticides (India) - 14112024 - khan